Fundraising Fox

Laetitia Schwab

Investor

Principal at SR One Capital Management

London

About

Laetitia Schwab is a Principal at SR One in the London office, joining in 2022. She previously worked in clinical development at Orchard Therapeutics, contributing to the delivery of the gene therapy Libmeldy for Marketing Authorisation, and has experience across early and late-phase clinical programs with expertise in gene therapy, neuroscience, and rare diseases. She holds a B.Sc in Medical Sciences from the University of Edinburgh, an MPhil in Translational Medicine and a Ph.D in Clinical Neuroscience from the University of Cambridge, and an MBA from INSEAD.

ContactΒ· self-published, not guessed

Invests in

Biotech

Experience

  1. SR One Capital ManagementPrincipalcurrent2026 β€” presentLondon, England, United Kingdom
  2. SR One Capital ManagementSenior Associate2024 β€” 2026London Area, United Kingdom
  3. SR One Capital ManagementAssociate2022 β€” 2026London Area, United Kingdom
  4. Draig TherapeuticsBoard Membercurrent2025 β€” present
  5. Addition TherapeuticsBoard Membercurrent2025 β€” present
  6. Avenzo TherapeuticsBoard Observercurrent2022 β€” present
  7. Sofinnova PartnersVenture Capital MBA Intern2021
  8. Orchard TherapeuticsSenior Clinical Development Scientist2019 β€” 2020London, United Kingdom
  9. Orchard TherapeuticsClinical Development Scientist2017 β€” 2018London, United Kingdom
  10. GSKClinical Development Intern, Rare disease unit2016London, Royaume-Uni
  11. GlaxoSmithKlineClinical Development Intern, Rare Disease Unit2012GSK House, London
  12. Sanofi Pasteur MSDClinical Development Trainee2011RΓ©gion de Lyon, France

Skills & more

Pharmaceutical Industry14Microsoft Excel9Research11Neuroscience10Microsoft Office3Clinical Development5Clinical Research5Clinical Trials7Healthcare ConsultingConsulting2Life Sciences1

Languages English Β· French Β· Spanish

  • Future VC Summer 2021 β€” Future VC

From Laetitia's professional profile.

Investments

Per SEC Form D filings.

Colleagues at SR One Capital Management

Frequently asked questions

Who is Laetitia Schwab?
Laetitia Schwab is a Principal at SR One in the London office, joining in 2022. She previously worked in clinical development at Orchard Therapeutics, contributing to the delivery of the gene therapy Libmeldy for Marketing Authorisation, and has experience across early and late-phase clinical programs with expertise in gene therapy, neuroscience, and rare diseases. She holds a B.Sc in Medical Sciences from the University of Edinburgh, an MPhil in Translational Medicine and a Ph.D in Clinical Neuroscience from the University of Cambridge, and an MBA from INSEAD.
Where does Laetitia Schwab work?
Laetitia Schwab is Principal at SR One Capital Management.
What does Laetitia Schwab invest in?
Laetitia Schwab invests in Biotech.
What boards does Laetitia Schwab sit on?
Laetitia Schwab holds tracked board seats at Addition Therapeutics.
Where did Laetitia Schwab go to school?
Laetitia Schwab studied at INSEAD (Master of Business Administration - MBA, Business Administration and Management); University of Cambridge (Doctor of Philosophy (PhD), Clinical Neuroscience); University of Cambridge (Master of Philosophy (MPhil), Clinical Science: Translational Medicine and Therapeutics).

Same school

Shared employers